SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-025019
Filing Date
2021-05-06
Accepted
2021-05-06 16:24:50
Documents
14
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vir-8k_20210506.htm   iXBRL 8-K 34988
2 EX-99.1 vir-ex991_6.htm EX-99.1 301550
3 GRAPHIC gfskcj0yycwm000001.jpg GRAPHIC 20269
  Complete submission text file 0001564590-21-025019.txt   517250

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vir-20210506.xsd EX-101.SCH 5753
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20210506_lab.xml EX-101.LAB 19478
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20210506_pre.xml EX-101.PRE 11613
7 EXTRACTED XBRL INSTANCE DOCUMENT vir-8k_20210506_htm.xml XML 3550
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 21898201
SIC: 2836 Biological Products, (No Diagnostic Substances)